文献速递头颈部肿瘤放疗姑息放疗与转移瘤

含与不含洋甘菊的脂质体凝胶预防头颈部肿瘤患者放射性皮炎的比较:一项随机对照试验

Comparison of liposomal gel with and without addition of chamomile for prevention of radiation dermatitis in head and neck cancer patients: A randomized controlled trial.
PubMed 文献 · Radiother Oncol · 2024-07-19

该双盲随机对照试验纳入60例首次接受放疗的头颈部肿瘤患者,比较含洋甘菊提取物与不含洋甘菊的脂质体凝胶预防放射性皮炎的效果。含洋甘菊脂质体凝胶组干性脱屑发生率为76.9%(95%CI:57.9,89.0),脂质体凝胶组为88.9%(95%CI:71.9,96.1),两组差异无统计学意义(p=0.43)。含洋甘菊脂质体凝胶组报告的症状较少,且放射性皮炎分级较低,但两组各项结局均无统计学显著差异。

要点

  • 含洋甘菊脂质体凝胶组干性脱屑发生率76.9%(95%CI:57.9,89.0),脂质体凝胶组88.9%(95%CI:71.9,96.1),p=0.43,差异无统计学意义。
  • 干性脱屑发生时中位累积电离辐射剂量:含洋甘菊脂质体凝胶组48.0 Gy,脂质体凝胶组40.0 Gy。
  • 含洋甘菊脂质体凝胶组报告的症状较少,且放射性皮炎分级低于脂质体凝胶组,但两组结局无统计学显著差异。

核心结论

  • 两组各项结局均无统计学显著差异,但含洋甘菊脂质体凝胶组放射性皮炎分级低于脂质体凝胶组。
  • 与其他局部干预文献相比,含洋甘菊脂质体凝胶在该人群中管理和预防放射性皮炎方面显示出潜在优势,尚需进一步验证。
  • 本研究为设计未来研究提供了关键信息。

研究设计与样本

  • 双盲随机临床试验,招募60例首次接受放疗的头颈部肿瘤患者。
  • 主要结局为干性脱屑的发生及首次发生干性脱屑时的累积电离辐射剂量。
  • 次要结局为红斑、湿性脱屑、全局放射性皮炎及受试者自报症状的发生情况。
  • 临床试验注册(REBEC):RBR-92cts3。

主要发现

  • 干性脱屑发生率:含洋甘菊脂质体凝胶组76.9%(95%CI:57.9,89.0) vs 脂质体凝胶组88.9%(95%CI:71.9,96.1),p=0.43。
  • 干性脱屑发生时中位累积电离辐射剂量:含洋甘菊脂质体凝胶组48.0 Gy vs 脂质体凝胶组40.0 Gy。
  • 含洋甘菊脂质体凝胶组报告的症状较少。
  • 两组各项结局均无统计学显著差异,含洋甘菊脂质体凝胶组放射性皮炎分级低于脂质体凝胶组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 含洋甘菊脂质体凝胶在管理和预防放射性皮炎方面的潜在优势尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Head and neck cancer patients frequently develop radiation dermatitis (RD) during radiotherapy. We compared liposomal gel with and without chamomile extract for the prevention and management of RD in head and neck cancer patients undergoing radiotherapy. MATERIALS AND METHODS: Sixty participants undergoing radiotherapy for the first time for head and neck cancer were recruited in a double-blind randomized clinical trial. Primary outcomes were the occurrence of dry desquamation and the cumulative dose of ionizing radiation at the first occurrence of dry desquamation. Secondary outcomes were the occurrence of erythema, moist desquamation, global RD, and participant self-reported symptoms. RESULTS: Dry desquamation occurred in 76.9 % (95 % CI: 57.9, 89.0) of participants in the chamomile liposomal gel group and in 88.9 % (95 % CI: 71.9, 96.1) in the liposomal gel group (p = 0.43). The median cumulative dose of ionizing radiation when dry desquamation occurred was 48.0 Gy in the chamomile liposomal gel group and 40.0 Gy in the liposomal gel group. Fewer symptoms were reported in the chamomile liposomal gel group. CONCLUSION: No statistically significant differences in outcomes were found between the two groups, though the chamomile liposomal gel group presented with lower grades of RD than the liposomal gel group. In addition, when compared to the literature on other topical interventions to manage RD, our results show that chamomile liposomal gel has potential for better management and prevention of RD in this population, which should be further tested. This study provides crucial information to design future studies. Clinical Trials Registration (REBEC): RBR-92cts3.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Menêses AG, Ferreira EB, Vieira LAC, et al. Comparison of liposomal gel with and without addition of chamomile for prevention of radiation dermatitis in head and neck cancer patients: A randomized controlled trial. Radiother Oncol. 2024. PMID: 39032836. doi:10.1016/j.radonc.2024.110440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。